Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer
International Journal of Molecular Sciences · 09.06.2023 · 24 (12) · 9946
DOI: 10.3390/ijms24129946 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.06.2023. Verfasst von Louis Marstrand-Daucé und 5 weiteren Autor:innen. Beteiligte Einrichtung: INSERM UMR1149, Inflammation Research Center (CRI), Université Paris Cité, 75018 Paris, France. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Carcinoma in Situ. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inserm, Université Paris Cité, Gefluc-Les Entreprises Contre le Cancer.
Abstract (Originalsprache)
Adult pancreatic acinar cells show high plasticity allowing them to change in their differentiation commitment. Pancreatic acinar-to-ductal metaplasia (ADM) is a cellular process in which the differentiated pancreatic acinar cells transform into duct-like cells. This process can occur as a result of cellular injury or inflammation in the pancreas. While ADM is a reversible process allowing pancreatic acinar regeneration, persistent inflammation or injury can lead to the development of pancreatic intraepithelial neoplasia (PanIN), which is a common precancerous lesion that precedes pancreatic ductal adenocarcinoma (PDAC). Several factors can contribute to the development of ADM and PanIN, including environmental factors such as obesity, chronic inflammation and genetic mutations. ADM is driven by extrinsic and intrinsic signaling. Here, we review the current knowledge on the cellular and molecular biology of ADM. Understanding the cellular and molecular mechanisms underlying ADM is critical for the development of new therapeutic strategies for pancreatitis and PDAC. Identifying the intermediate states and key molecules that regulate ADM initiation, maintenance and progression may help the development of novel preventive strategies for PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INSERM UMR1149, Inflammation Research Center (CRI), Université Paris Cité, 75018 Paris, France.
- Department of Pathology, Bichat Hospital, Université Paris Cité, 75018 Paris, France.
ORCID-Profile: Louis Marstrand-Daucé, Cécile Haumaitre
Förderung
- Inserm
- Université Paris Cité
- Gefluc-Les Entreprises Contre le Cancer
- la Ligue Contre le Cancer-Comité de Paris
- Fondation ARC
Zitieren
APA
Marstrand-Daucé, L., Lorenzo, D., Chassac, A., Nicole, P., Couvelard, A., & Haumaitre, C. (2023). Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer. International Journal of Molecular Sciences, 24(12), 9946. https://doi.org/10.3390/ijms24129946
Vancouver
Marstrand-Daucé L, Lorenzo D, Chassac A, Nicole P, Couvelard A, Haumaitre C. Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer. International Journal of Molecular Sciences. 2023;24(12):9946. doi:10.3390/ijms24129946
BibTeX
@article{MarstrandDauc2023,
author = {Marstrand-Daucé, Louis and Lorenzo, Diane and Chassac, Anaïs and Nicole, Pascal and Couvelard, Anne and Haumaitre, Cécile},
title = {Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {12},
pages = {9946},
doi = {10.3390/ijms24129946}
}
EUVIMED